Top Markets
Coin of the day
Upstream Bio, Inc. Upstream Bio, Inc.

Upstream Bio, Inc.

UPB
Rangering i aksjer #15300
Upstream Bio, Inc. is a biotechnology company in the clinical development... Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Established in 2021, Upstream Bio maintains its operational base in Waltham, Massachusetts.
Aksjekurs
$6.64
Sist synkronisert: 2026-08-31
Markedsverdi
$361.08M
Endring (1 dag)
-0.82%
Endring (1 år)
-61.27%
Land
US
Handel Upstream Bio, Inc. (UPB)

Kategori

Historikk for aksjesplitt for Upstream Bio, Inc. (UPB)
Aksjen Upstream Bio, Inc. (symbol: UPB) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Sep 01, 2026.
Én UPB-aksje kjøpt før Sep 01, 2026 tilsvarer i dag 0 UPB-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH